4-substituted aminoisoquinoline derivatives

US11001559B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11001559-B2
Application numberUS-201716325022-A
CountryUS
Kind codeB2
Filing dateAug 15, 2017
Priority dateAug 15, 2016
Publication dateMay 11, 2021
Grant dateMay 11, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention relates to 4-substituted isoquinoline compounds and their derivatives and uses thereof for treatment of cancer, for example, acute myeloid leukemia.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound represented by a formula of HSN608: or a pharmaceutically acceptable salt, N-oxide, hydrate, solvate, tautomer or optical isomer thereof. 2. A pharmaceutical composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt, N-oxide, hydrate, solvate, tautomer, or optical isomer thereof, and a pharmaceutically acceptable carrier or diluent.

Assignees

Inventors

Classifications

  • with hetero atoms directly attached in positions 2 and 4 · CPC title

  • Nitrogen atom · CPC title

  • linked by a carbon chain containing aromatic rings · CPC title

  • Nitrogen atoms · CPC title

  • Spiro-condensed systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11001559B2 cover?
This invention relates to 4-substituted isoquinoline compounds and their derivatives and uses thereof for treatment of cancer, for example, acute myeloid leukemia.
Who is the assignee on this patent?
Purdue Research Foundation
What technology area does this patent fall under?
Primary CPC classification C07D217/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).